The marketing authorization holder has informed its supplied customers in a letter dated June 19, 2013, that due to a manufacturing problem and the…

The marketing authorization holder informed its supplied customers in a letter dated June 18, 2013, that due to an individual complaint from the…

The marketing authorization holder informed its supplied customers in a letter dated June 3, 2013, that in the course of stability tests after 24…

The marketing authorization holder has informed its supplied customers in a letter dated 24.05.2013 that particles were observed in some vials. For…

During a routine test, leaks in the area of the predetermined breaking point at the neck of an amber glass ampoule of the size 1 ml were discovered in…

The marketing authorization holder informed its customers in a letter dated April 18, 2013, that due to a technical defect during production, isolated…

The marketing authorization holder has informed its supplied customers and medical home pharmacies that a microbiological contamination has been…

The distributor informed its supplied customers that during stability tests after a storage period of more than two years the specifications of the…

The marketing authorization holder has informed its supplied customers that preliminary results from the HPS2-THRIVE study (Heart Protection Study…

The marketing authorization holder informed its supplied customers in a letter dated Dec. 20, 2012, that the batch would be replaced due to unusual…